Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New drug AB598 takes first steps against advanced cancers

NCT ID NCT05891171

First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 21 times

Summary

This early-phase study tests a new drug called AB598, alone or with other treatments, in about 40 people with advanced solid tumors like lung, bladder, or ovarian cancer. The main goal is to check if the drug is safe and tolerable. Participants must have measurable tumors and be in good enough health to join.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Adelaide Cancer Research

    Adelaide, Australia

  • Affinity Health Hope and Healing Cancer Services, LLC

    Hinsdale, Illinois, 60521, United States

  • Gabrail Cancer Center (GCC) Canton Facility

    Canton, Ohio, 44718, United States

  • Karmanos Cancer Institute

    Detroit, Michigan, 48201, United States

  • Lake City Cancer Care, LLC.

    Lake City, Florida, 32024, United States

  • Mayo Clinic Arizona

    Phoenix, Arizona, 85054, United States

  • Mayo Clinic Florida

    Jacksonville, Florida, 32224, United States

  • Mayo Clinic Rochester

    Rochester, Minnesota, 55905, United States

  • National Cheng Kung University Hospital

    Tainan, Taiwan

  • Next Oncology Dallas

    Irving, Texas, 75039, United States

  • Next Oncology Virginia

    Fairfax, Virginia, 22031, United States

  • Queen Elizabeth Hospital

    Adelaide, Australia

  • Rutgers Cancer Institute of New Jersey

    New Brunswick, New Jersey, 08901, United States

  • Taipei Veterans General Hospital

    Taipei, Taiwan

  • University Hospitals Cleveland Medical Center

    Cleveland, Ohio, 44106, United States

Conditions

Explore the condition pages connected to this study.